ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Associate Director, Raw Materials Lead at ProKidney - ApplyBlast

Associate Director, Raw Materials Lead

ProKidney

25 days ago

3.9 on Glassdoor

Winston-Salem, North Carolina, United States

Onsite

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Associate Director, Raw Materials Lead establishes and leads the technical strategy and lifecycle management program for raw materials used in GMP manufacturing. This role translates CMC and manufacturing strategy into risk-based material control plans and supports BLA readiness, process validation, and commercial launch preparation. The position serves as a key technical leader for pre-license inspection activities and cross-functional initiatives to ensure product quality and manufacturability.

Responsibilities

Establish technical strategy and governance framework for raw materials in GMP manufacturing
Lead cross-functional initiatives to develop material control strategies and supplier qualification
Support BLA readiness, process validation, and commercial launch preparation activities

Skills

Qualifications

Bachelor's degree in Biological Sciences, Engineering, Pharmaceutical Sciences, or related discipline

About ProKidney

prokidney.com

Headquarters

Winston-Salem, North Carolina, United States

Company Size

51-200 employees

View Profile

ProKidney is a late clinical‑stage biotechnology company developing a first‑in‑class cell therapy candidate to treat advanced chronic kidney disease (CKD). Their lead program aims to preserve kidney function in patients who have limited therapeutic options and to transform the therapeutic landscape for progressive CKD. As a pioneer in CKD therapeutics, ProKidney is advancing clinical development to demonstrate safety and efficacy of regenerative approaches. The company focuses on addressing a major unmet need in kidney disease through novel cell‑based treatments.